FredricDGordonMD, FAASLD, FAST, AGAF

PubMed

• 82 citations
  Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
  Kris V. Kowdley, David J. Brandhagen, Robert G. Gish, Nathan M. Bass, Jeffrey Weinstein
  Gastroenterology. 2005-08-01
• 2026 citations
  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
  Michael Malinchoc, Patrick S. Kamath, Fredric D. Gordon, Craig J. Peine, Jeffrey M. Rank
  Hepatology. 2000-04-01
• 150 citations
  The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt
  Fredric D. Gordon, Harry Anastopoulos, W Crenshaw, B Gilchrist, N. Mceniff
  Hepatology. 1997-06-01

Journal Articles

• REFINE: A randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C  
  Levy G, Villamil FG, Nevens F, Metselaar HJ, Clavien P-A, Klintmalm G, Jones R, Migliaccio M, Prestele H, Orsenigo R, on behalf of the REFINE Study Group, American Journal of Transplantation, 1/1/2014
• Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection-a randomized trial  
  Poordad F, Lawitz E, Reddy KR, Afdhal NH, Hezode C, Zeuzem S, Lee SS, Calleja JL, Brown RS, Craxi A, Wedemeyer H, Nyberg L, Nelson DR, Rossaro L, Balart L, Morgan TR, ..., Gastroenterology, 1/1/2013
• Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: The randomized Spare-the-Nephron trial  
  Teperman L, Moonka D, Sebastian A, Sher L, Marotta P, Marsh C, Koneru B, Goss J, Preston D, Roberts JP; Spare-the-Nephron Trial Liver Transplantation Study Group, Liver Transplantation, 1/1/2013
• Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial  
  Sulkowski MS, Poordad F, Manns MP, Bronowicki JP, Rajender Reddy K, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Br..., Hepatology, 1/1/2013
• Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: A randomized controlled study  
  Chung R, Gordon FD, Curry MP, Schiano TD, Emre S, Corey K, Markmann J, Hertl M, Pomposelli JJ, Pomfret EA, Florman S, Schilsky M, Broering TJ, Finberg RW, Szabo G, Zam..., American Journal of Transplantation, 1/1/2013
• Ascites  
  Gordon FD, Clinics in Liver Disease, 1/1/2012
• Peginterferon alfa-2b and ribavirin for hepatitis C recurrence post-orthotopic liver transplantation  
  Gordon FD, Kwo P, Ghalib R, Crippin J, Vargas HE, Brown KA, Schiano T, Chaudhri E, Pedicone LD, Brown RS, Journal of Clinical Gastroenterology, 1/1/2012
• Factors that predict response of patients with hepatitis C infection to boceprevir  
  Poordad F, Bronowicki JP, Gordon S, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Moloney C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, ..., Gastroenterology, 1/1/2012
• Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia  
  Afdahl NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D; ELEVATE Study G..., New England Journal of Medicine, 1/1/2012
• PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin prophylactic treatment after liver transplant for HCV  
  Bzowej N, Nelson D, Terrault NA, Everson GT, Teng LL, Prabhakar A, Charlton MR; PHOENIX Study Group, Liver Transplantation, 1/1/2011
• Boceprevir for Untreated Chronic HCV Genotype 1 Infection  
  Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Brono..., New England Journal Medicine, 1/1/2011
• Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics  
  Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P; Terlipressin Study Group, Journal of Hepatology, 1/1/2011
• Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type I  
  Boyer TD, Sanyal AJ, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Gulberg V, Sigal S, Bexon AS, Teuber P, and the Terlipressin Study Group, Liver Transplantation, 1/1/2011
• Racial Differences in Hepatitis C Treatment Eligibility  
  Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Novie..., Hepatology, 1/1/2011
• Hepatitis C treatment among racial and ethnic groups in the IDEAL trial  
  Muir AJ, Hu K-Q, Gordon SC, Koury K, Boparai N, Noviello S, Albrecht JK, Sulkowski MS, McCone J; IDEAL Study Team, Journal of Viral Hepatitis, 1/1/2011
• Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate  
  Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK,..., Gastroenterology, 1/1/2010
• Successful outcome of portopulmonary syndrome in living donor liver transplant recipients Liver Transplantation  
  Bandara M, Gordon FD, Sarwar A, Knauft ME, Pomfret EA, Freeman RB, Wirth JA, Liver Transplantation, 1/1/2010
• Detection of WA B cells in HCV infection: A potential prognostic marker for cryoglobulinemic vasculitis and B cell lymphomas  
  Knight GB, Gao L, Gragnani L, Elfahal MM, DeRosa FG, Gordon FD, Agnello V, Arthritis and Rheumatism, 1/1/2010
• Rare Cutaneous Manifestation of Hyperbilirubinemia  
  Aaron RS, Zacharias I, Mannion S, Gordon FD, Archives of Dermatology, 1/1/2010
• Treatment of Hepatitis C in Liver Transplant Recipients  
  Gordon FD, Kwo P, Vargas H, Liver Transplantation, 1/1/2009
• Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival  
  Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA, Liver Transplantation, 1/1/2009
• Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection  
  McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, ..., N Engl J Med, 1/1/2009
• Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis  
  McPartland KJ, Lewis WD, Gordon FD, Pomfret EA, Pomposelli JJ, Jenkins R, Khettery U, Pathology International, 1/1/2009
• Utility of Lens culinaris Agglutinin-Reactive Fraction of alpha Fetoprotein and Des-Gamma-Carboxy Prothrombin, Alone or in Combination as Biomarkers for Hepatocellular...  
  RK Sterling, L Jeffers, F Gordon, AP Venook, KR Reddy, S Satomura, F Kanke, ME Schwartz, Sherman M, Clinical Gastroenterology and Hepatology, 1/1/2009
• Successful Algorithm for Selective Liver Biopsy in the Right Hepatic Lobe Donor  
  Simpson MA, Verbesey JE, Khettry U, Morin DS, Gordon FD, Burns DL, Robson K, Pomposelli JJ, Jenkins RL, Pomfret EA, American Journal of Transplantation, 4/1/2008
• Join now to see all

Books/Book Chapters

• Aparelho Digestivo Clinica e Cirurgia Vol 2 
  Chapter: Doencas Hepaticas Causadas por Medicamentos e Agentes Quimicos (Liver Disease Caused by Drugs and Chemical Agents). 
  Page 1513 - 1522Gordon FDEditors: Coehlo J.Atheneu, Sao Paulo, Brazil2012
• Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions 
  Chapter: Question 32: Which Patients with Hepatocellular Cancer are Candidates for Liver Transplantation or Surgical Resection? 
  Page 165 - 167Swales CT, Gordon FDEditors: Adler D.SLACK Inc., Thorofare, NJ2011
• Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions 
  Chapter: Question 35: A 55-year-old Man with Cirrhosis is Found to have a 1.5-cm Liver Lesion and an Elevated Alpha-Fetoprotein. Is a Biopsy or Other Testing Required to Confirm a Diagnosis of Hepatocellular C 
  Page 179 - 182Gordon FDEditors: Adler D.SLACK Inc., Thorofare, NJ2011
• 100 Questions and Answers about Liver, Heart, and Kidney Transplantation 
  Gilligan HM, Venesy DM, Gordon FDEditors: Jones and Bartlett Publishers.Sudbury, MA2010
• 100 Questions and Answers about Liver Transplantation 
  Gordon FDEditors: Jones and Bartlett Publishers.Sudbury, MA2007
• Medical Management of Liver Diseases 
  Chapter: Management of the Patient Awaiting Liver Transplantation. 
  Page 591 - 606Gordon FD, Lewis WD, Jenkins RLEditors: Krawitt E.Marcel Dekker, NY1999
• Liver and Biliary Diseases 
  Chapter: Sclerosing Cholangitis. 
  Page 755 - 769Gordon FD, LaRusso NF, Wiesner RHEditors: Kaplowitz N.Williams and Wilkins, BaltimoreEdition 2nd,1996
• Principles and Practice of Endocrinology and Metabolism 
  Chapter: Gastrointestinal Complications of Diabetes Mellitus. 
  Page 1280 - 1283Gordon FD and Falchuk KREditors: Becker KL.JB Lippincott Company, PhiladelphiaEdition 2nd,1995
• Join now to see all

Abstracts/Posters

• High Sustained Virologic Response Rates in Liver Transplant Recipients With Recurrent HCV Genotype 1 Infection Receiving ABT-450/r/Ombitasvir+Dasabuvir Plus Ribavirin.
  Kwo PY, Mantry P, Coakley E, Te H, Vargas HE, Brown R, Gordon FD, Levitsky J, Terreault N, Burton J, Xie W, Setze CM, Badri P, Vilchez RA, Forns X, Hepatitis Plenary, AASLD, Boston, MA, 11/11/2014
• Insurance Approval Patterns for Second-Generation DAAs.
  Gordon FD, Qamar AA, Hogan PM, Daponte LV, Simpson MA, AASLD, Boston, MA, 11/10/2014
• Prevention of Hepatitis C Virus (HCV) Recurrence with Peri-transplant Hepatitis C Immunoglobulin Combined with Pretransplant (Pre-LT) Antiviral Therapy (AVT).
  Terrault N, Therapondos G, Gordon FD, AASLD, Boston, MA, 11/9/2014
• Risk Factors for Recurrence of Primary Sclerosing Cholangitis in Live and Deceased Donor Liver Transplant Recipients in the A2ALL Study.
  Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM, Transplant Plenary I, AASLD, Boston, MA, 11/9/2014
• Sofosbuvir + Simeprevir Is Safe in Liver Transplant Recipients.
  Gordon FD, Kosinski AL, Coombs SJ, Goucher P, Aljahdli ES, Pomfret EA, AASLD, Boston, MA, 11/8/2014
• Impact of EGF, IL28B, and PNPLA3 Polymorphisms on the Outcome of Allograft Hepatitis C: A Multicenter Study.
  King LY, Mueller JL, Johnson KB, Gao T, Nephew L, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon F..., AASLD, Boston, MA, 11/1/2014
• Results of the Phase 2 Study M12-999: Interferon-free Regimen of ABT-450/r/ABT-267 + ABT-333 + Ribavirin in Liver Transplant Recipients with Recurrent HCV Genotype 1 I...
  Kwo P, Mantry P, Coakley E, Te H, Vargas H, Brown R, Gordon F, Levitsky J, Terrault N, Burton J, Xie W, Setze C, Badri P, Vilches RA, Forns X, World Transplant Congress, San Francisco, CA, 7/29/2014
• Interferon-free Regimen of ABT-450/R/ABT-267 + ABT-333 + Ribavirin in Liver Transplant Recipients with Recurrent HCV Genotype 1 Infection. Oral Presentation.
  Kwo P, Mantry P, Coakley E, Te H, Vargas H, Brown R, Gordon F, Levitsky J, Terrault N, Burton J, Xie W, Setze C, Badri P, Vilches RA, Forns X, European Association for the Study of the Liver, London, UK, 4/12/2014
• Pretransplant Sofosbuvir and Ribavirin to Prevent Recurrence of HCV Infection after Liver Transplantation. Presidential Plenary: Viral Hepatitis.
  Curry MP, Forns X, Chung RT, Terrault N, Brown RS, Fenkel JM, Gordon FD, O'Leary JG, Kuo A, Schiano TD, Everson GT, Schiff ER, Befeler A, McHutchison JG, Symonds WT, D..., AASLD, Washington, DC, 11/4/2013
• Hepatitis C Screening Rates at a Single Center after the Release of a CDC Recommendation to Screen All Adults Born Between 1945 and 1965.
  Albers C, Qamar AA, Tellier MA, Gordon FD, AASLD, Washington, DC, 11/4/2013
• An Analysis of Hepatology Relative Value Units (RVU), Patient Encounters, Salary, and Hospital Financial Support in Four Transplant Centers. Liver Transplantation.
  Trotter J, Gordon F, Shrestha R, Wakil E, AASLD, Boston, 11/10/2012
• Failure of Hepatitis B Vaccination in Chronic HBV Transplant Recipients.
  Gordon FD, Coombs S, Goucher P, Pomposelli JJ, Pomfret EA, AASLD, Boston, 11/10/2012
• Segment V or VIII hepatic venous reconstruction in liver donor adult liver transplantation (LDALT) using right lobe grafts.
  Dacosta MA, Pomfret EA, McPartland KJ, Simpson MA, Gordon FD, Lewis WD, Jenkins RL, Pomposelli JJ, American Journal of Transplantation, 1/1/2007
• Sustained virological response (SVR) in liver transplant recipients with hepatitis C (HCV) treated with Peginterferon and Ribavirin.
  Gordon FD, Morin D, Simpson MA, Davis CA, Khettry U, Yeh F, Pomposelli JJ, Pomfret EA, American Journal of Transplantation, 1/1/2007
• Clinical utility of AFP-L3% in patients with hepatitis C virus (HCV) related cirrhosis.
  Sterling RK, Jeffers L, Gordon F, et al, Hepatology, 1/1/2006
• Impact of MELD (Model for end stage liver disease) scoring system on findings at and after liver transplantation.
  Azabdaftari G, Simpson M, Pomfret E, Pomposelli J, Lewis W, Gordon F, Jenkins R, Khettry U, Modern Pathology, 1/1/2005
• Longitudinal analysis of donor quality of life after living donor liver transplantation.
  Verbesey JE, Simpson MA, Richman E, Nixon A, Gordon FD, Pomposelli JJ, Lewis WD, Jenkins RL, Pomfret EA, American Journal of Transplantation; 2004 American Transplant Congress, Boston, MA, 1/1/2004
• Cyclooxygenase-2 (COX-2) is highly expressed in cirrhosis and hepatocellular carcinoma.
  Pazirandeh S, Gordon FD, Yantiss RK, Khettry U, Sheth SG, Gastroenterology, 1/1/2004
• The severity of recurrent hepatitis C (HCV) in living donor adult liver transplant (LDALT) recipients is the same as cadaver (CAD) recipients.
  Gordon FD, Pomfret EA, Pomposelli JJ, Keaveny A, Simpson MA, Lewis WD, Morin D, Khettry U, Jenkins RL, American Journal of Transplantation, 1/1/2004
• Biliary complications after living donor liver transplantation.
  Verbesey JE, Pomfret EA, Pomposelli JJ, Akoud M, Simpson MA, Gordon FD, Lewis WD, Jenkins RL, American Journal of Transplantation; 2004 American Transplant Congress, Boston, MA, 1/1/2004
• Liver transplantation (LT) for primary sclerosing cholangitis (PSC): a pathologic study. Poster presentation at the United States and Canadian Academy of Pathology Mee...
  Goldar-Najafi A,  Keaveny A, Gordon F, Lewis W, Pomfret E, Pomposelli J, Jenkins R, Khettry U, Modern Pathology, 1/1/2003
• Liver regeneration and surgical outcome in donors of right lobe liver grafts.
  Pomfret EA, Pomposelli JJ, Burns D, Gordon FD, Goldberg ED, Lewis D, Jenkins RL, Hepatology, 1/1/2002
• Factors influencing the extent of hepatic regeneration after live donor liver transplantation (LDALT).
  Pomfret EA, Pomposelli JJ, Gordon FD, Goldberg ED, Lewis D, Jenkins RL, Hepatology, 1/1/2002
• The impact of pre-transplant methadone and narcotic use on transplant candidacy and outcomes.
  Gordon FD, Richman E, Nixon A, Pratt J, Conway P, Goldberg ED, Pomposelli JJ, Pomfret WD, Lewis WD, Hepatology, 1/1/2002
• Graft and patient survival in patients with HCV undergoing living donor liver transplantation compared to cadaveric liver transplantation.
  Goldberg ED, Gordon FD, Pomfret EA, Pomposelli JJ, Fabry SC, Lewis WD, Jenkins RL, Hepatology, 1/1/2002
• Join now to see all

Lectures

• Moderator and Lecturer, "Various topics" 
  Brewster, MA, 1999-2013 - 1/1/2014
• Pulmonary and Critical Care Grand Rounds: "Fulminant Hepatic Failure" 
  Lahey Hospital & Medical Center, Burlington, MA - 1/1/2014
• Medical Grand Rounds: "Non-Alcoholic Fatty Liver Disease" 
  Lowell General Hospital, Lowell, MA - 1/1/2014
• "Hepatitis C Update in the Fall, 2014" 
  Waltham, MA - 1/1/2014
• "Non-Alcoholic Fatty Liver Disease: The Hepatologist's Perspective" (Guest Faculty) 
  Montreal, Canada - 1/1/2014
• "New Therapy for Hepatitis C" (Guest Lecturer) 
  Bermuda - 1/1/2014
• Medical Grand Rounds: "Liver Transplantation: A Medical Perspective" (Guest Lecturer) 
  King Edward VII Hospital, Bermuda - 1/1/2014
• "Hereditary Hemochromatosis: 2013" (Guest Faculty) 
  Burlington, MA - 1/1/2013
• Transplant Grand Rounds: "Hemochromatosis" 
  Lahey Clinic Medical Center, Burlington, MA - 1/1/2013
• Transplant Grand Rounds: "Direct Acting Antivirals after Liver Transplantation" 
  Lahey Clinic Medical Center, Burlington, MA - 1/1/2013
• Transplant Grand Rounds: "Current Insight into Hepatic Encephalopathy" 
  Lahey Hospital & Medical Center, Burlington, MA - 1/1/2013
• "Complications of Portal Hypertension: What To Do?" 
  Los Angeles, CA - 1/1/2013
• "What's New in Transplant" 
  Los Angeles, CA - 1/1/2013
• "Direct Acting Antivirals for HCV Post-Liver Transplant" 
  Seattle, WA - 1/1/2013
• "Mid-Day Symposia: Update on Hepatitis C in Transplantation" 
  Seattle, WA - 1/1/2013
• Medical Grand Rounds: "Viral Hepatitis from A to G: An Overview" 
  St. Vincent Hospital, Worcester, MA - 1/1/2012
• Internal Medicine Rounds: "Viral Hepatitis" 
  Lahey Wilmington, Wilmington, MA - 1/1/2012
• Medical Grand Rounds: "Overview of Liver Disease: A Tall Order" 
  Lowell General Hospital, Lowell, MA - 1/1/2012
• "Hepatitis C Update 2012" 
  Waltham, MA - 1/1/2012
• "Everything You Need to Know about Hepatitis C" (Guest Faculty) 
  Ogunquit, ME - 1/1/2012
• "Combating HCV: How the PCP Can Make a Difference" 
  Boston, MA - 1/1/2012
• Keynote Speaker, "Hepatitis C-What's New in Treatment and Outcomes" 
  Freeport, ME - 1/1/2010
• Gastroenterology Grand Rounds: "Live Donor Liver Transplantation" 
  Beth Israel Deaconess Medical Center, Boston, MA - 1/1/2010
• "Upcoming Treatment for Hepatitis C" 
  Haverhill, MA - 1/1/2010
• Gastroenterology Grand Rounds: "New Concepts and Treatments for Hepatitis C" 
  Tufts Medical Center, Boston, MA - 1/1/2010
• Join now to see all

Other

• Cholestatic Hepatitis C in Immune Compromised Settings. 
  Zacharias IA, Gordon FD, Current Hepatitis Reports: Hepatitis C-Complex Clinical Issues
  1/1/2009
• Liver Transplantation. 
  Gordon FD, Numedx
  1/1/2003
• Detecting Disease: Early Diagnosis is Key for Hepatitis C. 
  Gordon, FD
  http://abcnews.go.com/sections/living/DailyNews/hepatitisc020321.html
  3/21/2002
• Understanding Liver Transplantation. 
  Gordon, FD, WebMD Live Event
  4/11/2000
• Keynote speaker, "Hepatitis C Review" 
  Fredric D. Gordon, MD, "House Calls on Hepatitis C", WJAR TV/10 and WJFD-AM
  Cranston, RI - 1/1/2000
• Keynote speaker, "Liver Transplantation Update" 
  Fredric D. Gordon, MD, "House Calls on Hepatitis C", WJAR TV/10 and WJFD-AM
  Cranston, RI - 1/1/2000
• Liver Transplantation in Primary Biliary Cirrhosis. 
  Flamm S, Chopra S, Gordon F, UpToDate in Medicine (CD-ROM), BDR-UpToDate, Inc.
  MA - 1/1/1996
• Liver transplantation in primary biliary cirrhosis 
  Gordon FD, Poupon R, Flamm S
  http://www.uptodate.com/contents/liver-transplantation-in-primary-biliary-cirrhosis
  UpToDate, Wolters Kluwer Health - 2012-12-10
• Join now to see all